Physalin A showed antiproliferative effect in non-small cell lung cancer by activating apoptosis through inhibition of the JAK/STAT3 signaling pathway. In addition, physalin A significantly suppressed tumor xenograft growth. Here, STAT3 is linked to non-small cell lung carcinoma.